In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections

被引：66

作者：

Edmiston, CE

Krepel, CJ

Seabrook, GR

Somberg, LR

Nakeeb, A

Cambria, RA

Towne, JB

机构：

[1] Med Coll Wisconsin, Dept Surg, Div Vasc Surg, Milwaukee, WI 53226 USA

[2] Med Coll Wisconsin, Dept Surg, Div Trauma & Crit Care, Milwaukee, WI 53226 USA

[3] Med Coll Wisconsin, Dept Surg, Div Pancreatobiliary Surg, Milwaukee, WI 53226 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 03期

关键词：

D O I：

10.1128/AAC.48.3.1012-1016.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activities of moxifloxacin, ciprofloxacin, levofloxacin, gatifloxacin, imipenem, piperacillintazobactam, clindamycin, and metronidazolle against 900 surgical isolates were determined using NCCLS testing methods. Moxifloxacin exhibited good to excellent antimicrobial activity against most aerobic (90.8%) and anaerobic (97.1%) microorganisms, suggesting that it may be effective for the treatment of polymicrobial surgical infections.

引用

收藏

页码：1012 / 1016

页数：5

相关论文

共 23 条

[1] Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria [J].

Ackermann, G ;

Schaumann, R ;

Pless, B ;

Claros, MC ;

Goldstein, EJC ;

Rodloff, AC .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (03) :228-232

[2] Bacteremia due to Bacteroides fragilis group:: distribution of species, β-lactamase production, and antimicrobial susceptibility patterns [J].

Aldridge, KE ;

Ashcraft, D ;

O'Brien, M ;

Sanders, CV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :148-153

[3] Quinolone activity against anaerobes [J].

Appelbaum, PC .

DRUGS, 1999, 58 (Suppl 2) :60-64

[4] Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and β-lactams [J].

Behra-Miellet, J ;

Dubreuil, L ;

Jumas-Bilak, E .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (05) :366-374

[5]

Calhoun Jason H, 2002, Adv Skin Wound Care, V15, P31, DOI 10.1097/00129334-200201000-00011

[6]

Condon RE, 1999, INFECTION, V27, P63

[7] Pharmacodynamics of antimicrobial therapy in surgery [J].

DiPiro, JT ;

Edmiston, CE ;

Bohnen, JMA .

AMERICAN JOURNAL OF SURGERY, 1996, 171 (06) :615-622

[8] Penetration of ciprofloxacin and fleroxacin into biliary tract [J].

Edmiston, CE ;

Suarez, EC ;

Walker, AP ;

Demeure, MP ;

Frantzides, CT ;

Schulte, WJ ;

Wilson, SD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :787-788

[9]

EDMISTON CE, 2002, SURG INFECT S1, V2, pS13

[10] Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents [J].

Ednie, LM ;

Rattan, A ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :1143-1147